SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (9747)10/17/2006 12:59:48 PM
From: Iamarangerboy  Respond to of 10280
 
of course, the real value to the Lunesta 7 day trial is that docs that have not used L might become more familiar with it. Assuming that it costs less than $1 per pill to produce and distribute, at a $7 cost, a doc gets "detailed" by a patient. Probably more cost efficient than using sale representatives who are on relatively large salaries ;-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News